BSX vs ZBH
BSX and ZBH side by side — valuation & fundamentals (public data).
Key statistics
| Metric | BSXBOSTON SCIENTIFIC CORP | ZBHZIMMER BIOMET HOLDINGS, INC. |
|---|---|---|
| Market cap | $65.43B | $17.63B |
| P/E (TTM) | 18.4 | 23.6 |
| P/B | 2.53 | 1.39 |
| P/S | 3.3x | 2.1x |
| Dividend yield | — | 1.08% |
| Revenue | $20.61B(TTM) | $8.41B(TTM) |
| Revenue growth (YoY) | 19.9% | 7.2% |
| Net income | — | $761.20M(TTM) |
| Earnings growth (YoY) | — | -22.0% |
| EPS, diluted | $2.39(TTM) | $3.86(TTM) |
| EBIT margin | 18.0% | 13.3% |
| ROE | 0.0% | 5.6% |
| ROIC | 10.5% | 5.0% |
| Piotroski F | — | 6/9 |
| 1y total return | -57.9% | -2.9% |
Figures from SEC filings · for reference only · not investment advice
$10,000 투자 성장: BSX vs ZBH
| 지표 | BSX | ZBH |
|---|---|---|
| 최종 가치 | $24.6K | $9.5K |
| 총수익률 | +145.8% | -4.8% |
| CAGR | +9.1% | -0.5% |
| 변동성 | 27.3% | 28.3% |
| 샤프 | 0.32 | -0.01 |
| 소르티노 | 0.43 | -0.01 |
| 최대 낙폭 | -60.6% | -53.5% |
공통 거래일 2600일 기준, 2016-03-15 → 2026-07-17 · 무위험수익률 3.85% (현재 단기 국채 금리, 고정 적용)
A head-to-head total-return backtest over real split- and dividend-adjusted prices: how a one-time $10,000 investment in each stock, held to today, would have grown over their common window — including reinvested dividends. A disclosed historical statistic — NOT a prediction, a guarantee, or investment advice. Past performance does not predict future results.
Related comparisons
Delayed data · Public sources · For reference only · Not investment advice (this page declares no winner)